Lipid profile of human synovial fluid following intra‐articular ankle fracture
Authors:
Open Access
- 29 February 2016
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 35 (3) , 657-666
Abstract
This study characterizes the metabolic profile of synovial fluid after intra‐articular ankle fracture with an emphasis on changes in the lipid profile. Bilateral ankle synovial fluid from 19 patients with unilateral intra‐articular ankle fracture was submitted for metabolic profiling. Contralateral ankle synovial fluid from each patient served as a matched control. Seven patients participated in a second bilateral synovial fluid collection after 6 months. Random forest classification, matched pairs t‐tests (α < 0.01), repeated measures ANOVA with post‐test contrasts (α < 0.01), correlation to cytokines and matrix metalloproteinases, and fracture and injury classification analyses yielded key lipid biomarkers in synovial fluid following intra‐articular fracture. Free fatty acids, sphingomyelins, and lysolipids demonstrated significant elevation in fractured ankles at baseline. Fatty acids and sphingomyelins showed a significant decrease 6 months post‐surgery. Random forest analysis showed predominantly fatty acids differentiating between groups. Significant correlations included fatty acids, sphingomyelins, and lysolipids with inflammatory cytokines and matrix metalloproteinases. Fracture classification showed increased fatty acids, lysolipids, and inositol metabolites as fracture severity increased. Fatty acid and sn‐1 lysolipid elevation could be detrimental to the joint, as these strongly correlated with matrix metalloproteinases and TNF‐α. This elevation also suggests involvement of phospholipase A2, a potential target for therapeutic intervention. Together with elevated 2‐hydroxyl fatty acids, these findings suggest elevated sn‐1 lysolipids, sphingomyelins, and subsequent lipid metabolites in synovial fluid as biomarkers of ankle injury. Reversal of this signature after 6 months suggests temporary involvement of these metabolites in disease progression, although they may activate signaling pathways which drive progression to osteoarthritis. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:657–666, 2017.Keywords
Funding Information
- National Institutes of Health (R01AR047422)
This publication has 50 references indexed in Scilit:
- Global metabolic profiling of human osteoarthritic synoviumOsteoarthritis and Cartilage, 2012
- Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse kneeOsteoarthritis and Cartilage, 2011
- Post‐traumatic osteoarthritis: Improved understanding and opportunities for early interventionJournal of Orthopaedic Research, 2011
- Specialized pro-resolving lipid mediators in the inflammatory response: An updateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritisEMBO Molecular Medicine, 2010
- Fatty acid 2-Hydroxylation in mammalian sphingolipid biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Etiology of Ankle OsteoarthritisClinical Orthopaedics and Related Research, 2009
- Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injuryArthritis & Rheumatism, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Measurement of synovial fluid volume using ureaOsteoarthritis and Cartilage, 2007